Idexx Laboratories Inc De (IDXX) SEC Filing 8-K Material Event for the period ending Friday, June 28, 2019

Idexx Laboratories Inc De

CIK: 874716 Ticker: IDXX

View differences made from one to another to evaluate Idexx Laboratories Inc De's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Idexx Laboratories Inc De.


Assess how Idexx Laboratories Inc De's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Idexx Laboratories Inc De's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Idexx Laboratories Inc De provided additional information to their SEC Filing as exhibits

Ticker: IDXX
CIK: 874716
Form Type: 8-K Corporate News
Accession Number: 0001144204-19-033248
Submitted to the SEC: Mon Jul 01 2019 8:30:40 AM EST
Accepted by the SEC: Mon Jul 01 2019
Period: Friday, June 28, 2019
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: